Human Liver Sample | Antibody | 7EFC O-Deethylase Activity | Reference Assay | Reference Assay Activity |
---|---|---|---|---|
% | % | |||
HLS2 | MAB-2A6 | 80 | Coumarin 7-hydroxylase | 18 |
HLS9 | MAB-2A6 | 108 | Coumarin 7-hydroxylase | 14 |
HLS5 | MAB-2E1 | 88 | p-Nitrophenol hydroxylase | 10 |
HLS6 | MAB-2E1 | 67 | p-Nitrophenol hydroxylase | 10 |
HLS5 | Anti-CYP1A2 | 56 | PhenacetinO-deethylase | 8 |
HLS9 | Anti-CYP1A2 | 100 | PhenacetinO-deethylase | 8 |
HLS5 | Anti-CYP2C13 | 89 | Diclofenac 4′-hydroxylase | 15 |
HLS5 | Anti-CYP2C13 | 89 | (S)-Mephenytoin 4′-hydroxylase | 22 |
7EFC O-deethylase (5 μM substrate), phenacetinO-deethylase (200 μM substrate), diclofenac 4′-hydroxylase (100 μM substrate), (S)-mephenytoin 4′-hydroxylase (100 μM substrate), p-nitrophenol hydroxylase (50 μM substrate), and coumarin 7-hydroxylase (200 μM substrate) activities were assayed as described in Materials and Methods.Antibodies were used as described in Materials and Methods.Values shown are the means of two determinations and represent the percentage of activity in the absence of anti-CYP antibodies.